Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Sep;67(9):e28432.
doi: 10.1002/pbc.28432. Epub 2020 Jul 6.

Severe COVID-19 disease in two pediatric oncology patients

Claire L Stokes  1   2 , Pratik A Patel  1   2 , Himalee S Sabnis  1   2 , Sarah G Mitchell  1   2 , Inci B Yildirim  3 , Melinda G Pauly  1   2
Affiliations
Case Reports

Severe COVID-19 disease in two pediatric oncology patients

Claire L Stokes et al. Pediatr Blood Cancer. 2020 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Chest CT imaging of patient 1 on hospital day 0 showed scattered ground glass and consolidative opacities (arrow) in bilateral lower lobes. CT, computerized tomography
FIGURE 2
FIGURE 2
A, Trends of ferritin (green), maximum daily temperature (red), C‐reactive protein (blue), and supplemental oxygen (black) of patient 1. Hydroxychloroquine was started on hospital day 6 (HD 6), tocilizumab was given on HD 7 and 8, and remdesivir was started on HD 10. Patient 1 ICU course was from HD 7 to HD 14 (red bar). B, Trends of ferritin (green), maximum daily temperature (red), C‐reactive protein (blue), and supplemental oxygen (black) of patient 2. Hydroxychloroquine was started on HD 3 and remdesivir was started on HD 4. Patient 2 ICU course was from HD 0 to HD 10 (red bar). T max, maximum daily temperature in degrees Celsius; CRP, C‐reactive protein; HCQ, hydroxychloroquine; TCZ, tocilizumab; RDV, remdesivir
See this image and copyright information in PMC

References

    1. CDC COVID‐19 Response Team . Coronavirus disease 2019 in children ‐ United States, February 12‐April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422‐426. - PMC - PubMed
    1. Cruz AT, Zeichner SL. COVID‐19 in children: initial characterization of the pediatric disease. Pediatrics. 2020;. 145(5):e20200834. - PubMed
    1. Liu W, Zhang Q, Chen J, et al. Detection of COVID‐19 in children in early January 2020 in Wuhan, China. N Engl J Med. 2020;382(14):1370‐1371. - PMC - PubMed
    1. Lu X, Zhang L, Du H, et al. SARS‐CoV‐2 infection in children. N Engl J Med. 2020;382(17):1663‐1665. - PMC - PubMed
    1. Liang W, Guan W, Chen R, et al. Cancer patients in SARS‐CoV‐2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335‐337. - PMC - PubMed